These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 4852381)

  • 1. In vitro cellular immunity in mammary carcinoma.
    Jones BM; Turnbull AR
    Br J Cancer; 1974 Apr; 29(4):337-9. PubMed ID: 4852381
    [No Abstract]   [Full Text] [Related]  

  • 2. Cellular hypersensitivity of gp55 of RIII-murine mammary tumor virus and gp55-like protein of human breast cancers.
    Black MM; Zachrau RE; Dion AS; Shore B; Fine DL; Leis HP; Williams CJ
    Cancer Res; 1976 Nov; 36(11 Pt 1):4137-42. PubMed ID: 184925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunology: breast cancer.
    Heppner GH
    Recent Results Cancer Res; 1976; (57):95-108. PubMed ID: 189376
    [No Abstract]   [Full Text] [Related]  

  • 4. Assessment of cellular immune response to cancer of the breast.
    Herberman RB
    Ann Clin Lab Sci; 1979; 9(6):467-73. PubMed ID: 229763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular immunity to canine mammary tumor cells demonstrated by the leucocyte migration technique.
    Ulvund MJ
    Acta Vet Scand; 1975; 16(1):95-114. PubMed ID: 1136913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular immunity in mammary cancer patients as measured by the leukocyte migration test (LMT). A follow-up study.
    Rieche K; Arndt A; Pasternak G
    Int J Cancer; 1976 Feb; 17(2):212-8. PubMed ID: 1248905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular immunity to breast carcinoma and malignant melanoma.
    Cochran AJ; Mackie RM; Thomas CE; Grant RM; Cameron-Mowat DE; Spilg WG
    Br J Cancer Suppl; 1973 Aug; 1():77-82. PubMed ID: 4804293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular immunity to autologous breast cancer and RIII-murine mammary tumor virus preparations.
    Black MM; Zachrau RE; Shore B; Dion AS; Leis HP
    Cancer Res; 1978 Jul; 38(7):2068-76. PubMed ID: 207421
    [No Abstract]   [Full Text] [Related]  

  • 9. Sensitization to tumour-associated antigens in human breast carcinoma.
    Cochran AJ; Grant RM; Spilg WG; Mackie RM; Ross CE; Hoyle DE; Russell JM
    Int J Cancer; 1974 Jul; 14(1):19-25. PubMed ID: 4617707
    [No Abstract]   [Full Text] [Related]  

  • 10. Detection of cell-mediated immune reactivity of breast cancer patients by the leukocyte adherence inhibition response to MCF-7 extracts.
    Rudczynski AB; Dyer CA; Mortensen RF
    Cancer Res; 1978 Nov; 38(11 Pt 1):3590-4. PubMed ID: 81103
    [No Abstract]   [Full Text] [Related]  

  • 11. [Transplantation antigens and their immunological activity].
    Artsimovich NG; Nastoiashchaia NN; Kudrina GP; Mondrus KA; Sukhorukova JM
    Usp Sovrem Biol; 1975; 80(2):254-69. PubMed ID: 1108491
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunologic relationship between breast carcinoma and benign breast disease as detected by the leukocyte migration inhibition assay.
    Cannon GB; McCoy JL; Jerome LJ; Reddick R; Alford C; Tinley V; Herberman RB
    J Natl Cancer Inst; 1978 Nov; 61(5):1181-6. PubMed ID: 280705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity and MuMTV-like antigenicity of human breast cancer tissues.
    Black MM
    Contemp Top Immunobiol; 1977; 6():239-62. PubMed ID: 194749
    [No Abstract]   [Full Text] [Related]  

  • 14. Prognostically favorable immunogens of human breast cancer tissue: antigenic similarity to murine mammary tumor virus.
    Black MM; Zachrau RE; Shore B; Moore DH; Leis HP
    Cancer; 1975 Jan; 35(1):121-8. PubMed ID: 162850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukocyte migration inhibition response to various antigen preparations of autologous and homologous breast cancer in patients with primary breast cancer.
    Fukuda M; Wanebo HJ; Tsuei L; Sarkar NH
    J Natl Cancer Inst; 1979 Nov; 63(5):1161-9. PubMed ID: 91696
    [No Abstract]   [Full Text] [Related]  

  • 16. Antitumor immunity in breast cancer patients. Biologic and therapeutic implications.
    Black MM; Zachrau RE
    J Reprod Med; 1979 Jul; 23(1):21-32. PubMed ID: 226697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro evaluation of cell-mediated immunity in mice: experiments with soluble and cellular antigens in a spleen-thymus cell leucocyte migration test (LMT).
    Ranlov P; Hardt F
    Clin Exp Immunol; 1971 Feb; 8(2):163-71. PubMed ID: 4929774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunopathology of breast cancer.
    Black MM
    Pathobiol Annu; 1977; 7():213-30. PubMed ID: 201905
    [No Abstract]   [Full Text] [Related]  

  • 19. Reactivity of lung cancer patients in leukocyte migration inhibition assays to 3-M potassium chloride extracts of fresh tumor and tissue-cultured cells derived from lung cancer.
    McCoy JL; Jerome LF; Cannon GB; Weese JL; Herberman RB
    J Natl Cancer Inst; 1977 Nov; 59(5):1413-8. PubMed ID: 909101
    [No Abstract]   [Full Text] [Related]  

  • 20. Antigen-reactive cells to tumor antigens in normal and tumor patients.
    Falk RE; MacGregor AB
    J Surg Res; 1976 Mar; 20(3):247-53. PubMed ID: 772313
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.